中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Functional structural domain synthesis of anti-pancreatic carcinoma pectin-like polysaccharide RN1

文献类型:期刊论文

作者Cai, Deqin1,2; He, Fei1,2; Wu, Shengjie1,2; Wang, Zixuan1,2; Bian, Ya1,2; Wen, Chang1,2; Ding, Kan1,2,3,4
刊名CARBOHYDRATE POLYMERS
出版日期2024-03-01
卷号327页码:11
关键词Polysaccharide Pectin Functional structural domain Pancreatic cancer Glycan synthesis RN1
ISSN号0144-8617
DOI10.1016/j.carbpol.2023.121668
通讯作者Ding, Kan(dingkan@simm.ac.cn)
英文摘要The great structural and functional diversity supports polysaccharides as favorable candidates for new drug development. Previously we reported that a drug candidate pectin-like natural polysaccharide, RN1 might target galectin-3 (Gal-3) to impede pancreatic cancer cell growth in vivo. However, the quality control of polysaccharide-based drug research faces great challenges due to the heterogeneity. A potential solution is to synthesize structurally identified subfragments of this polysaccharide as alternatives. In this work, we took RN1 as an example, and synthesized five subfragments derived from the putative repeating units of RN1. Among them, pentasaccharide 4 showed an approximative binding affinity to Gal-3 in vitro, as well as an antiproliferative activity against pancreatic BxPC-3 cells comparable to that of RN1. Further, we scaled up pentasaccharide 4 to gram-scale in an efficient synthetic route with a 6.9 % yield from D-galactose. Importantly, pentasaccharide 4 significantly suppressed the growth of pancreatic tumor in vivo. Based on the mechanism complementarity of galactin-3 inhibitor and docetaxel, the combination administration of pentasaccharide 4 and docetaxel afforded better result. The result suggested pentasaccharide 4 was one of the functional structural domains of polysaccharide RN1 and might be a leading compound for anti-pancreatic cancer new drug development.
WOS关键词GALECTIN-3 ; CANCER ; ANGIOGENESIS ; GEMCITABINE ; DOCETAXEL ; HEPARIN ; CELL
资助项目National Key Research and Devel- opment Program of China[2022YFA1303802] ; Shanghai Municipal Science and Technology Major Project ; National Natural Science Foundation of China[32271332] ; National Natural Science Foundation of China[31870801] ; Yangfan Project of Shanghai Science and Technology Commission[20YF1457300] ; High-level New R D Institute[2019B090904008] ; Department of Science and Technology of Guangdong Province[2021B0909050003] ; Zhongshan Science and Technology Bureau ; Zhongshan Municipal Bureau of Science and Technology
WOS研究方向Chemistry ; Polymer Science
语种英语
WOS记录号WOS:001136395300001
出版者ELSEVIER SCI LTD
源URL[http://119.78.100.183/handle/2S10ELR8/308529]  
专题中国科学院上海药物研究所
通讯作者Ding, Kan
作者单位1.Univ Chinese Acad Sci, Sch Med, 19A Yuquan Rd, Beijing 100049, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Carbohydrate Drug Res Ctr, Glycochemistry & Glycobiol Lab, Shanghai 201203, Peoples R China
3.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528400, Peoples R China
4.Chinese Acad Sci, Shanghai Inst Mat Med, Glycochemistry & Glycobiol Lab, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Cai, Deqin,He, Fei,Wu, Shengjie,et al. Functional structural domain synthesis of anti-pancreatic carcinoma pectin-like polysaccharide RN1[J]. CARBOHYDRATE POLYMERS,2024,327:11.
APA Cai, Deqin.,He, Fei.,Wu, Shengjie.,Wang, Zixuan.,Bian, Ya.,...&Ding, Kan.(2024).Functional structural domain synthesis of anti-pancreatic carcinoma pectin-like polysaccharide RN1.CARBOHYDRATE POLYMERS,327,11.
MLA Cai, Deqin,et al."Functional structural domain synthesis of anti-pancreatic carcinoma pectin-like polysaccharide RN1".CARBOHYDRATE POLYMERS 327(2024):11.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。